期刊文献+

帕瑞昔布钠用于上肢骨折手术对芬太尼术后镇痛效果的影响 被引量:3

The Influence of Parecoxib Sodium on the Postoperative Analgesic Effect of Fentanyl for Upper Limb Fracture Surgery
在线阅读 下载PDF
导出
摘要 目的探讨帕瑞昔布钠用于上肢骨折手术对芬太尼术后镇痛效果的影响。方法将90例患者分为对照组和实验组,在手术结束前15min,对照组患者给予静脉注射2mL生理盐水,实验组患者给予静脉注射40mg帕瑞昔布钠。结果术后5、7、11h组间VAS评分比较差异有统计学意义(P<0.05);术后2、24h两组间的VAS评分比较,差异无统计学意义(P>0.05);与对照组相比,实验组患者镇痛泵按压次数以及镇痛泵外芬太尼静脉追加次数明显低于对照组,差异有统计学意义(P<0.05);实验组患者嗜睡、恶心等不良症状的发生率较低(P<0.05)。结论帕瑞昔布钠能够有效减少上肢骨折手术芬太尼静脉镇痛的不良反应以及有效提高术后镇痛效果,具有安全性和有效性。 Objective To explore the influence of parecoxib sodium on the postoperative analgesic effect of fentanyl for upper limb fracture surgery. Methods Ninty cases were were divided into control and experimental groups, 15min before the end of surgery, the control group was treated with intravenous saline 2mL and the experimental group was treated with intravenous parecoxib sodium 40rag. Results Postoperative 5,7,11 hours,VAS scores between groups had statistically significant difference(P〈0.05);Postoperative 2,24 hours, VAS scores between the two groups had no statistically significant difference(P〉0.05);Comparing with the control group,the press numbers of analgesic pump and additional number of intravenous fentanyl outside the analgesic pump of experimental group were significantly lower than those of the control group, and the differences were statistically significant (P〈0.05);The incidences of drowsiness, nausea and other adverse symptoms of experimental group were lower (P〈0.05). Conclusion Parecoxib sodium can effectively reduce the adverse effects of fentanyl for upper limb fracture surgery and effectively improve the analgesic effect, with the safety and effectiveness.
作者 刘栋
出处 《中国现代医生》 2011年第34期98-99,共2页 China Modern Doctor
关键词 帕瑞昔布钠 上肢骨折手术 芬太尼 镇痛效果 Parecoxib sodium Upper limb fracture surgery Fentanyl Analgesic effect
  • 相关文献

参考文献7

二级参考文献46

  • 1吴新民,岳云,张利萍,王俊科,艾登滨,于布为,薛张纲,黄文起.术后镇痛中帕瑞昔布钠对吗啡用量的节俭作用和安全性—前瞻性、多中心、随机、双盲、安慰剂对照、平行分组研究[J].中华麻醉学杂志,2007,27(1):7-10. 被引量:367
  • 2Bensen WG, Fiechtner JJ, McMillen JI, et al. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial. Mayo Clin Proc, 1999; 74:1095-1105.
  • 3Gierse JK, McDonald JJ, Hauser SD, et al. A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors, J Biol Chem, 1996, 271(26): 15810-15814.
  • 4Apfelbaum JL, Desjardins PJ, Brown MT, et al. Multiple-day efficacy ofparecoxib sodium treatment in postoperative bunionectomy pain. Clin JPain, 2008, 24(9): 784-792.
  • 5Michael C, Artur J, Kotarski J, et al. Parecoxib sodium administered over several days reducespain after gynecologic surgery via laparotomy. ] Clin Anesth, 2007, 19:448-455.
  • 6Viscusi ER, Gimbel JS, Halder AM, et al. A multiple-day regimen of parecoxib sodium 20 mg twice daily provides pain relief after total hip arthroplasty. Anesth Analg, 2008, 107(2): 652-660.
  • 7Tang J, Li S, White PF, et al. Effect of parecoxib, a novel intravenous cyclooxygenase type-2 inhibitor, on the postoperative opioid requirement and quality of pain control. Anesthesiology, 2002, 96(6): 1305-1309.
  • 8Malan TP, Marsh G, Hakki SI, et al. Parecoxib sodium, a parenteral cyclooxygenase-selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty, Anesthesiology, 2003, 98: 950-957.
  • 9Jirarattanaphochai K, Thienthong S, Sriraj W, et al. Effect of parecoxib on postoperative pain after lumbar spine surgery. Spine, 2008, 33: 132-139.
  • 10Hubbard RC, Naumann TM, Traylor L, et al. Parecoxib sodium has opioid-sparing effects in patients undergoing total knee arthroplasty under spinal anaesthesia. Br J Anaesth, 2003, 90(2): 166-172.

共引文献79

同被引文献26

引证文献3

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部